Virtu Financial’s Kazia Therapeutics KZIA Stock Holding History

Virtu Financial’s Portfolio KZIA Stock Details KZIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-786	Closed	-$9K	–	1640
2024 Q2	$9K	Buy	+786	New	+$11.7K	﹤0.01%	1140
2024 Q1	–	Sell	-229	Closed	-$5K	–	1760
2023 Q4	$5K	Sell	229 -4	-2%	-$117	﹤0.01%	1470
2023 Q3	$12K	Buy	+233	New	+$11.4K	﹤0.01%	1081
2022 Q4	–	Sell	-246	Closed	-$14K	–	1906
2022 Q3	$14K	Buy	+246	New	+$27.5K	﹤0.01%	1471

Other funds holding KZIA

MCM

MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

UBV

United Bank (Virginia) Vienna, Virginia $781M AUM 27.1% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Virtu Financial's KZIA Position: Q3 2024 in Review

Virtu Financial sold out of Kazia Therapeutics (KZIA) in Q3 2024, closing a stake of 786 shares — an estimated $9K sold.

Virtu Financial first reported a position in KZIA in Q3 2022 and held it in 4 quarters. The position peaked at $14K in Q3 2022. 17 funds tracked by Wall St. Rank hold KZIA as of Q3 2024.

Virtu Financial reported no remaining Kazia Therapeutics position as of Q3 2024 after selling out during the quarter.
Virtu Financial sold 786 Kazia Therapeutics shares in Q3 2024, an estimated $9K.
Virtu Financial first reported a position in Kazia Therapeutics in Q3 2022 and held it in 4 quarters.
Virtu Financial's Kazia Therapeutics position peaked at $14K in Q3 2022.
17 funds tracked by Wall St. Rank held Kazia Therapeutics as of Q3 2024.

Based on Virtu Financial's 13F filing for Q3 2024, filed 20 Nov 2024.